{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T03:06:15Z","timestamp":1791083175847,"version":"4.1.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2018,8,17]],"date-time":"2018-08-17T00:00:00Z","timestamp":1534464000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Antibiot"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1038\/s41429-018-0090-7","type":"journal-article","created":{"date-parts":[[2018,8,17]],"date-time":"2018-08-17T05:23:03Z","timestamp":1534483383000},"page":"971-974","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":57,"title":["Evaluation of LL-37 antimicrobial peptide derivatives alone and in combination with vancomycin against S. aureus"],"prefix":"10.1038","volume":"71","author":[{"given":"James F.","family":"Shurko","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralph S.","family":"Galega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuxi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace C.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,8,17]]},"reference":[{"key":"90_CR1","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1128\/CMR.00134-14","volume":"28","author":"SYC Tonga","year":"2015","unstructured":"Tonga SYC, Davis JS, Eichenbergerb E, Hollandb TL, Fowler VG. Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management. Clin Microbiol Rev. 2015;28:603\u201361.","journal-title":"Clin Microbiol Rev"},{"key":"90_CR2","unstructured":"Centers for Disease Control and Prevention. Antibiotic resistance threats in the United States, 2013. \n                    www.cdc.gov\/drugresistance\/threat-report-2013\/\n                    \n                  .Accessed 2017."},{"key":"90_CR3","doi-asserted-by":"publisher","first-page":"45","DOI":"10.12968\/jowc.2010.19.2.46966","volume":"19","author":"RD Wolcott","year":"2010","unstructured":"Wolcott RD, et al. Chronic wounds and the medical biofilm paradigm. J Wound Care. 2010;19:45\u20136, 48\u201350, 52\u20133.","journal-title":"J Wound Care"},{"key":"90_CR4","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1016\/j.bbamem.2006.03.030","volume":"1758","author":"UHN D\u00fcrr","year":"2006","unstructured":"D\u00fcrr UHN, Sudheendra US, Ramamoorthy A. LL-37, the only human member of the cathelicidin family of antimicrobial peptides. Biochim Biophys Acta. 2006;1758:1408\u201325.","journal-title":"Biochim Biophys Acta"},{"key":"90_CR5","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1046\/j.1365-2958.2002.03146.x","volume":"46","author":"A Schmidtchen","year":"2002","unstructured":"Schmidtchen A, Frick IM, Andersson E, Tapper H, Bj\u00f6rck L. Proteinases of common pathogenic bacteria degrade and inactivate the antibacterial peptide LL-37. Mol Microbiol. 2002;46:157\u201368.","journal-title":"Mol Microbiol"},{"key":"90_CR6","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1084\/jem.192.7.1069","volume":"192","author":"D Yang","year":"2000","unstructured":"Yang D, et al. LL-37, the neutrophil granule- and epithelial cell-derived cathelicidin, utilizes formyl peptide receptor-like 1 (FPRL1) as a receptor to chemoattract human peripheral blood neutrophils, monocytes, and T cells. J Exp Med. 2000;192:1069\u201374.","journal-title":"J Exp Med"},{"key":"90_CR7","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1189\/jlb.0403147","volume":"75","author":"M Zanetti","year":"2004","unstructured":"Zanetti M. Cathelicidins, multifunctional peptides of the innate immunity. J Leukoc Biol. 2004;75:39\u201348.","journal-title":"J Leukoc Biol"},{"key":"90_CR8","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1124\/pr.55.1.2","volume":"55","author":"MR Yeaman","year":"2003","unstructured":"Yeaman MR, Yount NY. Mechanisms of antimicrobial peptide action and resistance. Pharmacol Rev. 2003;55:27\u201355.","journal-title":"Pharmacol Rev"},{"key":"90_CR9","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1038\/nrmicro1098","volume":"3","author":"KA Brogden","year":"2005","unstructured":"Brogden KA. Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria? Nat Rev Microbiol. 2005;3:238\u201350.","journal-title":"Nat Rev Microbiol"},{"key":"90_CR10","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1128\/AAC.01650-12","volume":"57","author":"J Noore","year":"2013","unstructured":"Noore J, Noore A, Li B. Cationic antimicrobial peptide LL-37 is effective against both extra- and intracellular Staphylococcus aureus. Antimicrob Agents Chemother. 2013;57:1283\u201390.","journal-title":"Antimicrob Agents Chemother"},{"key":"90_CR11","doi-asserted-by":"publisher","first-page":"4411","DOI":"10.1128\/AAC.02554-14","volume":"50","author":"ME Haisma","year":"2014","unstructured":"Haisma ME, et al. LL-37-derived peptides eradicate multidrug-resistant Staphylococcus aureus from thermally wounded human skin equivalents. Antimicrob Agents Chemother. 2014;50:4411\u20139.","journal-title":"Antimicrob Agents Chemother"},{"key":"90_CR12","doi-asserted-by":"publisher","first-page":"404","DOI":"10.4236\/abb.2011.26059","volume":"2","author":"BJ Moncla","year":"2011","unstructured":"Moncla BJ, Prykek K, Rohan LC, Graebing PW. Degradation of naturally occurring and engineered antimicrobial peptides by proteases. Adv Biosci Biotechnol. 2011;2:404\u20138.","journal-title":"Adv Biosci Biotechnol"},{"key":"90_CR13","doi-asserted-by":"publisher","first-page":"40891","DOI":"10.1074\/jbc.M112.404582","volume":"287","author":"A Hollands","year":"2012","unstructured":"Hollands A, et al. A bacterial pathogen co-opts host plasmin to resist killing by cathelicidin antimicrobial peptides. J Biol Chem. 2012;287:40891\u20137.","journal-title":"J Biol Chem"},{"key":"90_CR14","doi-asserted-by":"publisher","first-page":"4673","DOI":"10.1128\/AAC.48.12.4673-4679.2004","volume":"48","author":"M Sieprawska-Lupa","year":"2004","unstructured":"Sieprawska-Lupa M, et al. Degradation of human antimicrobial peptide LL-37 by Staphylococcus aureus-derived proteinases. Antimicrob Agents Chemother. 2004;48:4673\u20139.","journal-title":"Antimicrob Agents Chemother"},{"key":"90_CR15","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1042\/bj3410501","volume":"341","author":"Z Oren","year":"1999","unstructured":"Oren Z, Lerman JC, Gudmundsson GH, Agerberth B, Shai Y. Structure and organization of the human antimicrobial peptide LL-37 in phospholipid membranes: relevance to the molecular basis for its non-cell-selective activity. Biochem J. 1999;341:501\u201313.","journal-title":"Biochem J"},{"key":"90_CR16","doi-asserted-by":"publisher","first-page":"3718","DOI":"10.1074\/jbc.273.6.3718","volume":"273","author":"J Johansson","year":"1998","unstructured":"Johansson J, Gudmundsson GH, Rottenberg ME, Berndt KD, Agerberth A. Conformation-dependent antibacterial activity of the naturally occurring human peptide LL-37. J Biol Chem. 1998;273:3718\u201324.","journal-title":"J Biol Chem"},{"key":"90_CR17","first-page":"1574","volume":"12","author":"MF Burton","year":"2009","unstructured":"Burton MF, Steel PG. The chemistry and biology of LL-37. Nat Prod Rep. 2009;12:1574\u201382.","journal-title":"Nat Prod Rep"},{"key":"90_CR18","unstructured":"Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing: twenty-fourth informational supplement M100-S24. Wayne, PA: CLSI; 2014."},{"key":"90_CR19","first-page":"2437","volume":"47","author":"GA O\u2019toole","year":"2011","unstructured":"O\u2019toole GA. Microtiter dish biofilm formation assay. J Vis Exp. 2011;47:2437.","journal-title":"J Vis Exp"},{"key":"90_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/srep29707","volume":"6","author":"MF Mohamed","year":"2016","unstructured":"Mohamed MF, Abdelkhalek A, Seleem MN. Evaluation of short synthetic antimicrobial peptides for treatment of drug-resistant and intracellular Staphylococcus aureus. Sci Rep. 2016;6:29707.","journal-title":"Sci Rep"}],"container-title":["The Journal of Antibiotics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41429-018-0090-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41429-018-0090-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41429-018-0090-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:31:21Z","timestamp":1684618281000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41429-018-0090-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,17]]},"references-count":20,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2018,11]]}},"alternative-id":["90"],"URL":"https:\/\/doi.org\/10.1038\/s41429-018-0090-7","relation":{},"ISSN":["0021-8820","1881-1469"],"issn-type":[{"value":"0021-8820","type":"print"},{"value":"1881-1469","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,17]]},"assertion":[{"value":"21 May 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 July 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 July 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 August 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}